Overview of Oncologic Emergencies
Spring J, Munshi L. Hematology Emergencies in Critically Ill Adults: Malignant Hematology.
Chest. 2022 Feb 12:S0012-3692(22)00248-3.
Chemotherapy in the ICU
Lafarge A, Chean D, Whiting L, et. al; Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Intensive Care Med. 2024 Jun;50(6):849-860.
Hyperleukocytosis and Leukostasis
Shallis RM, Stahl M, Bewersdorf JP,et al. Leukocytapheresis for patients with acute myeloid leukemia presenting withhyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Expert Rev Hematol. 2020;13(5):489-499.
Giammarco S, Chiusolo P, Piccirillo N, et al. Hyperleukocytosis and leukostasis: management of a medical emergency.
Rev Hematol. 2017;10(2):147-154.
Rollig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia.
Blood. 2015;125(21):3246-3252.
Novel Therapies
Gutierrez C, Rajendram P, Pastores SM. Toxicities Associated with Immunotherapy and Approach to Cardiotoxicity with Novel Cancer Therapies.
Crit Care Clin. 2021;37(1):47 - 67.
Boll B, Subklewe M, von Bergwelt - Baildon M. Ten things the hematologist wants you to know about CAR - T cells.
Intensive Care Med. 2020;46(6):1243 - 1245.
Gutierrez C, McEvoy C, Munshi L, et al. Critical Care Management of Toxicities Associated with Targeted Agents and Immunotherapies for Cancer.
Crit Care Med. 2020;48(1):10 - 21.
Lemiale V, Meert AP, Vincent F, et al. Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?
Ann Intensive Care. 2019;9(1):25.
Postow MA, Sidlow R, Hellmann MD. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
N Engl J Med. 2018;378(2):158-168.
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, et al. Critical care management of chimeric antigen receptor T-cell therapy recipients.
CA Cancer J Clin. 2022;72(1):78-93.
Respiratory Failure in Immunocompromised Patients
Azoulay E, Mokart D, Kouatchet A, et al . Acute respiratory failure in immunocompromised adults.
Lancet Respir Med. 2019;7(2):173 - 186.
Azoulay E, Russell L, Van de Louw A, et al. Diagnosis of severe respiratory infections in immunocompromised patients.
Intensive Care Med. 2020;46(2):298-314.
Buchtele N, Munshi L. Acute Respiratory Distress Syndrome in the Immunocompromised Patient.
Clin Chest Med. 2024 Dec;45(4):929-941.
Chean D, Maillard A, Benattia A, et al. Acute respiratory failure in adult patients with acute myeloid leukemia.
Expert Rev Respir Med. 2024 Dec;18(12):963-974.
Ferreyro BL, Munshi L. Causes of acute respiratory failure in the immunocompromised host.
Curr Opin Crit Care. 2019;25(1):21-28.
Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation.
Expert Rev Respir Med. 2019;13(1):105-119.
Septic Shock in Immunocompromised Patients
Nates JL, Pène F, Darmon M, et al. Nine-I Investigators. Septic shock in the immunocompromised cancer patient: a narrative review.
Crit Care. 2024 Aug 30;28(1):285.
SIADH and Hyponatremia
Yasir M, Mechanic OJ. Syndrome of Inappropriate Antidiuretic Hormone Secretion. In: StatPearls.
Treasure Island (FL) 2021.
Workeneh BT, Jhaveri KD, Rondon-Berrios H. Hyponatremia in the cancer patient.
Kidney Int. 2020;98(4):870-882.
Stem Cell Transplant
Fornwalt RA, Brigham EP, Scott Stephens R. Critical Care of Hematopoietic Stem Cell Transplant Patients.
Crit Care Clin. 2021;37(1):29-46.
Randolph BV, Ciurea SO. What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation? In: Nates JL, Price KJ, eds.
Oncologic Critical Care. Cham: Springer International Publishing; 2020:1531-1546.
Tumor Lysis Syndrome
Adeyinka A, Bashir K. Tumor Lysis Syndrome. In:
StatPearls. Treasure Island (FL)2021.
Kala J, Finkel KW. Onconephrology.
Crit Care Clin. 2021;37(2):365-384.
Durani U, Hogan WJ. Emergencies in haematology: tumour lysis syndrome.
Br J Haematol. 2020;188(4):494-500.